Drug discovery companies are customizing ChatGPT: here’s how
Published in Drugs development.
Large language models are helping scientists to converse with artificial intelligence and even to generate potential drug targets.
Much of the world has been transfixed in recent months by the appearance of text generation engines such as OpenAI’s ChatGPT, artificial intelligence (AI) algorithms capable of producing text that seems as if it were written by a human. While tech companies like Microsoft and Google are focused on using such engines as a way to improve search and others worry they could cause a rash of plagiarized essays, fake news and bad poetry, biotechs are looking at these algorithms to bolster their businesses, as a method to contribute to drug discovery in a variety of ways.